Commentary: What those with rare diseases want us to consider

Anxiety over a disease with as yet no vaccine or cure was already daily life for 30 million Americans.

By Carolina Sommer / For The Herald

Just three short months ago, nobody knew a virus now known as SARS-CoV-2 would spread to almost every country at an alarming rate; emptying public spaces, breaking down health-care systems, crashing economies, and forcing us to “hunker” down at home. I’m scared as I hear infection rates spiking and more people dying.

As a perpetual optimist, however, I can’t help but think through a “silver linings” lens during this pandemic; perhaps this crisis can be used as a wake-up call for “normal,” healthy Washingtonians to truly understand what it’s like to have a disease without a cure or treatment readily available.

Today, individuals living with a rare condition face the kind of uncertainty that many across the globe are facing today. Namely, how soon can we access the next cure, vaccine, or best possible treatment?

As the chief executive officer of the Bothell-based organization, Born a Hero, I know this sentiment well. Most — if not all my time — is spent ensuring my board and staff are doing everything we can to accelerate innovation through research and support groups to improve the quality of life for patients with Fibroblast Growth Factor Receptor (FGFR) Syndromes.

This includes my daughter.

For those of you that don’t know, FGFR Syndromes are comprised of 15 separate rare disorders, including Pfeiffer Syndrome; which impairs the way bones fuse or grow. If issues related to Pfeiffer Syndrome are not treated early, they can result in serious impairments. Or even death.

Pfeiffer Syndrome is just one of the approximately 7,000 diseases classified as “rare,” which is defined as any disease, disorder, illness or condition affecting fewer than 200,000 people in the United States. According to the National Organization for Rare Disorders, more than 90 percent of rare diseases are without an FDA-approved treatment.

As I sit at home “sheltering in place” with my family, I find myself thinking of all those impacted by COVID-19, constantly sending healthy thoughts and warm prayers to each and every individual and family dealing with this devastating health crisis.

But, if there’s anything I hope the healthiest of populations can take away from this pandemic, it’s a newfound realization of what it’s like to live with so much uncertainty as it pertains to one’s health.

While this is a new reality for most, it’s not for those affected by Pfeiffer Syndrome, nor with the 1 in every 10 Americans living with a rare or common disease.

Now, more than ever, is a time when the medical community — including health insurers, the pharmaceutical industry, and government regulators — must act fast to help those in need.

Thankfully we’re seeing signs of this happening.

For example, I was glad to see the federal government recently agreed to lift restrictions on telemedicine services for seniors under Medicare, enabling patients to access hospital-level medical care outside of hospitals in schools, hotels and homes.

Health advocates are also playing their part, urging Congress to cap the cost of prescription drugs under Part D. In recent years, very high prices of specialty drugs have burdened enrollees, mainly because Part D does not cap the total amounts that enrollees must pay out of pocket each year.

Additionally, industries are taking unprecedented steps by collaborating with competitors and the federal government to quickly develop antiviral therapies to help infected patients fight COVID-19, as well as new vaccines to prevent infection and curtail the spread of the virus.

These actions are impressive, promising and a true testament to how quickly we can act when the pressure is on.

But it makes me wonder: Global pandemic or not, couldn’t we all do more to ensure that the nearly 30 million Americans living with a rare disease have access to the best possible treatment, cure, or way of life, too?

Carolina Sommer is the chief executive officer of the Bothell-based organization Born a Hero.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Opinion

toon
Editorial cartoons for Thursday, Feb. 6

A sketchy look at the news of the day.… Continue reading

Curtains act as doors for a handful of classrooms at Glenwood Elementary on Monday, Sept. 9, 2024 in Lake Stevens, Washington. (Olivia Vanni / The Herald)
Editorial: Schools’ building needs point to election reform

Construction funding requests in Arlington and Lake Stevens show need for a change to bond elections.

Lake Stevens school bond funds needed safety work at all schools

A parent’s greatest fear is for something bad to happen to their… Continue reading

Arlington schools capital levy: Say yes to new Post Middle School

Schools are the backbone of the Arlington community. Families want to move… Continue reading

Long sentences not much of a deterrent but serve justice

A recent column by Todd Welch mentions a trope that ignores one… Continue reading

Comment: Trump’s stress-test of Constitution shows it’s up to job

Keep filing lawsuits and the courts will bat down his unconstitutional orders; as long as he follows the rulings.

Stephens: Trump endangers stability of Pax Americana

Discarding the values of a ‘Great Power’ for a ‘Big Power’ will cost the U.S. its standing in the world.

FILE- In this Nov. 14, 2017, file photo Jaìme Ceja operates a forklift while loading boxes of Red Delicious apples on to a trailer during his shift in an orchard in Tieton, Wash. Cherry and apple growers in Washington state are worried their exports to China will be hurt by a trade war that escalated on Monday when that country raised import duties on a $3 billion list of products. (Shawn Gust/Yakima Herald-Republic via AP, File)
Editorial: Trade war would harm state’s consumers, jobs

Trump’s threat of tariffs to win non-trade concessions complicates talks, says a state trade advocate.

A press operator grabs a Herald newspaper to check over as the papers roll off the press in March 2022 in Everett. (Olivia Vanni / The Herald file photo)
Editorial: Push back news desert with journalism support

A bill in the state Senate would tax big tech to support a hiring fund for local news outlets.

Jayden Hill, 15, an incoming sophomore at Monroe High School is reflected in the screen of a cellphone on Wednesday, July 10, 2024 in Monroe, Washington. (Olivia Vanni / The Herald)
Editorial: Students need limits on cellphones in school

School districts needn’t wait for legislation to start work on policies to limit phones in class.

toon
Editorial cartoons for Wednesday, Feb. 5

A sketchy look at the news of the day.… Continue reading

Comment: Costco’s work to defend its DEI values isn’t over

Costco successfully argued its values to shareholders, but a bigger fight looms with ‘anti-woke’ forces.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.